(Q63811827)
Statements
CLARIFY MS (English)
0 references
A 2-Year Prospective Study to Assess Health-related Quality of Life In Subjects With Highly-Active Relapsing Multiple Sclerosis Treated With Mavenclad® (English)
0 references
20 June 2018
0 references
25 November 2021
0 references
445
0 references
18 year
0 references